Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2012, Article ID 189290, 10 pages
http://dx.doi.org/10.1100/2012/189290
Research Article

Angiotensins Inhibit Cell Growth in GH3 Lactosomatotroph Pituitary Tumor Cell Culture: A Possible Involvement of the p44/42 and p38 MAPK Pathways

1Department of Endocrinology, The County Hospital of Kutno, 52 Kosciuszki Street, 99-300 Kutno, Poland
2Department of Immunoendocrinology, Chair of Endocrinology, Medical University of Lodz, Dr. Sterling 3 Street, 91-425 Lodz, Poland
3Clinic of Endocrinology, Medical University of Lodz, Dr. Sterling 3 Street, 91-425 Lodz, Poland

Received 18 October 2011; Accepted 22 December 2011

Academic Editor: Dzung H. Dinh

Copyright © 2012 Dorota Ptasinska-Wnuk et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. L. Goodfriend, “Angiotensins. A family that grows from within,” Hypertension, vol. 17, no. 2, pp. 139–140, 1991. View at Google Scholar · View at Scopus
  2. F. J. Villarreal, N. N. Kim, G. D. Ungab, M. P. Printz, and W. H. Dillmann, “Identification of functional angiotensin II receptors on rat cardiac fibroblasts,” Circulation, vol. 88, no. 6, pp. 2849–2861, 1993. View at Google Scholar · View at Scopus
  3. F. Xiao, J. R. Puddefoot, and G. P. Vinson, “The expression of renin and the formation of angiotensin II in bovine aortic endothelial cells,” Journal of Endocrinology, vol. 164, no. 2, pp. 207–214, 2000. View at Google Scholar · View at Scopus
  4. A. N. D. Cat and R. M. Touyz, “A new look at the renin-angiotensin system—focusing on the vascular system,” Peptides, vol. 32, no. 10, pp. 2141–2150, 2011. View at Publisher · View at Google Scholar
  5. J. W. Wright and J. W. Harding, “Brain renin-angiotensin—a new look at an old system,” Progress in Neurobiology, vol. 95, no. 1, pp. 49–67, 2011. View at Publisher · View at Google Scholar
  6. P. D. Bell and J. Peti-Peterdi, “Angiotensin II stimulates macula densa basolateral sodium/hydrogen exchange via type 1 angiotensin II receptors,” Journal of the American Society of Nephrology, vol. 10, no. 1, pp. S225–S229, 1999. View at Google Scholar · View at Scopus
  7. J. L. Zhuo and X. C. Li, “New insights and perspectives on intrarenal renin-angiotensin system: focus on intracrine/intracellular angiotensin II,” Peptides, vol. 32, no. 7, pp. 1551–1565, 2011. View at Publisher · View at Google Scholar
  8. D. T. Dinh, A. G. Frauman, M. Sourial, D. J. Casley, C. I. Johnston, and M. E. Fabiani, “Identification, distribution, and expression of angiotensin II receptors in the normal human prostate and benign prostatic hyperplasia,” Endocrinology, vol. 142, no. 3, pp. 1349–1356, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Fändriks, “The renin-angiotensin system and the gastrointestinal mucosa,” Acta Physiologica, vol. 201, no. 1, pp. 157–167, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. P. S. Leung, “Pancreatic RAS,” Advances in Experimental Medicine and Biology, vol. 690, pp. 89–105, 2010. View at Google Scholar
  11. P. S. Leung, “The renin-angiotensin system: current research progress in the pancreas,” in Advances in Experimental Medicine and Biology, vol. 690, part 2, pp. 69–87, Springer, Berlin, Germany, 2010. View at Google Scholar
  12. A. Reaux, X. Iturrioz, G. Vazeux et al., “Aminopeptidase A, which generates one of the main effector peptides of the brain renin-angiotensin system, angiotensin III, has a key role in central control of arterial blood pressure,” Biochemical Society Transactions, vol. 28, no. 4, pp. 435–440, 2000. View at Google Scholar · View at Scopus
  13. M. Tokioka-Terao, K. Hiwada, and T. Kokubo, “Purification and characterization of aminopeptidase N from human plasma,” Enzyme, vol. 32, no. 2, pp. 65–75, 1984. View at Google Scholar · View at Scopus
  14. S. H. Padia, B. A. Kemp, N. L. Howell et al., “Intrarenal aminopeptidase N inhibition augments natriuretic responses to angiotensin III in angiotensin type 1 receptor-blocked rats,” Hypertension, vol. 49, no. 3, pp. 625–630, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Paul, A. P. Mehr, and R. Kreutz, “Physiology of local renin-angiotensin systems,” Physiological Reviews, vol. 86, no. 3, pp. 747–803, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Louis, L. Saward, and P. Zahradka, “Both AT1 and AT2 receptors mediate proliferation and migration of porcine vascular smooth muscle cells,” American Journal of Physiology, vol. 301, no. 3, pp. H746–H756, 2011. View at Publisher · View at Google Scholar
  17. J. I. Sadoshima, Y. Xu, H. S. Slayter, and S. Izumo, “Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro,” Cell, vol. 75, no. 5, pp. 977–984, 1993. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Natarajan, N. Gonzales, P. J. Hornsby, and J. Nadler, “Mechanism of angiotensin II-induced proliferation in bovine adrenocortical cells,” Endocrinology, vol. 131, no. 3, pp. 1174–1180, 1992. View at Publisher · View at Google Scholar · View at Scopus
  19. P. E. McEwan, G. B. M. Lindop, and C. J. Kenyon, “In vivo studies of the control of DNA synthesis in the rat adrenal cortex and medulla,” Endocrine Research, vol. 21, no. 1-2, pp. 91–102, 1995. View at Google Scholar · View at Scopus
  20. A. Zhang, G. Ding, S. Huang et al., “c-Jun NH2-terminal kinase mediation of angiotensin II-induced proliferation of human mesangial cells,” American Journal of Physiology, vol. 288, no. 6, pp. F1118–F1124, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Bauer, A. Lametschwandtner, M. Steiner, and H. C. Bauer, “Influence of angiotensin converting enzyme inhibitor (captopril) on kidney epithelial cells in vitro: studies on potassium (86Rb) influx and cellular proliferation,” Clinica Chimica Acta, vol. 187, no. 1, pp. 47–53, 1990. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Wennemuth and G. Aumüller, “Angiotensin II-mediated calcium signals and mitogenesis in human prostate stromal cell line hPCPs,” British Journal of Pharmacology, vol. 144, no. 1, pp. 3–10, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Ławnicka, A. M. Potocka, A. Juzala, M. C. Fournie-Zaluski, and M. Pawlikowski, “Angiotensin II and its fragments (angiotensins III and IV) decrease the growth of DU-145 prostate cancer cells in vitro,” Medical Science Monitor, vol. 10, no. 11, pp. BR410–BR413, 2004. View at Google Scholar · View at Scopus
  24. M. Pawlikowski, G. Meleń-Mucha, and S. Mucha, “The involvement of the renin-angiotensin system in the regulation of cell proliferation in the rat endometrium,” Cellular and Molecular Life Sciences, vol. 55, no. 3, pp. 506–510, 1999. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Pawlikowski, A. Gruszka, S. Mucha, and G. Melen-Mucha, “Angiotensins II and IV stimulate the rat adrenocortical cell proliferation acting via different receptors,” Endocrine Regulations, vol. 35, no. 3, pp. 139–142, 2001. View at Google Scholar · View at Scopus
  26. M. Pawlikowski, G. Meleń-Mucha, and S. Mucha, “The involvement of angiotensins in the control of prostatic epithelial cell proliferation in the rat,” Folia Histochemica et Cytobiologica, vol. 39, no. 4, pp. 341–343, 2001. View at Google Scholar · View at Scopus
  27. Y. D. Li, E. R. Block, and J. M. Patel, “Activation of multiple signaling modules is critical in angiotensin IV-induced lung endothelial cell proliferation,” American Journal of Physiology, vol. 283, no. 4, pp. L707–L716, 2002. View at Google Scholar · View at Scopus
  28. Y. Izumi, S. Kim, Y. Zhan, M. Namba, H. Yasumoto, and H. Iwao, “Important role of angiotensin II-mediated c-Jun NH2-terminal kinase activation in cardiac hypertrophy in hypertensive rats,” Hypertension, vol. 36, no. 4, pp. 511–516, 2000. View at Google Scholar · View at Scopus
  29. T. Naito, T. Masaki, D. J. Nikolic-Paterson, C. Tanji, N. Yorioka, and N. Kohno, “Angiotensin II induces thrombospondin-1 production in human mesangial cells via p38 MAPK and JNK: a mechanism for activation of latent TGF-β 1,” American Journal of Physiology, vol. 286, no. 2, pp. F278–F287, 2004. View at Google Scholar
  30. R. M. Touyz, G. He, M. El Mabrouk, Q. Diep, V. Mardigyan, and E. L. Schiffrin, “Differential activation of extracellular signal-regulated protein kinase 1/2 and p38 mitogen activated-protein kinase by AT1 receptors in vascular smooth muscle cells from Wistar-Kyoto rats and spontaneously hypertensive rats,” Journal of Hypertension, vol. 19, no. 3, pp. 553–559, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. M. A. Clark and N. Gonzalez, “Angiotensin II stimulates rat astrocyte mitogen-activated protein kinase activity and growth through EGF and PDGF receptor transactivation,” Regulatory Peptides, vol. 144, no. 1–3, pp. 115–122, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. M. A. Clark, H. Tran, and C. Nguyen, “Angiotensin III stimulates ERK1/2 mitogen-activated protein kinases and astrocyte growth in cultured rat astrocytes,” Neuropeptides, vol. 45, no. 5, pp. 329–335, 2011. View at Publisher · View at Google Scholar
  33. B. E. Mugabe, F. A. Yaghini, C. Y. Song, C. K. Buharalioglu, C. M. Waters, and K. U. Malik, “Angiotensin II-induced migration of vascular smooth muscle cells is mediated by p38 mitogen-activated protein kinase-activated c-Src through spleen tyrosine kinase and epidermal growth factor receptor transactivation,” Journal of Pharmacology and Experimental Therapeutics, vol. 332, no. 1, pp. 116–124, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Blenis, “Signal transduction via the MAP kinases: proceed at your own RSK,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 13, pp. 5889–5892, 1993. View at Google Scholar · View at Scopus
  35. Y. Keshet and R. Seger, “The MAP kinase signaling cascades: a system of hundreds of components regulates a diverse array of physiological functions,” Methods in Molecular Biology, vol. 661, pp. 3–38, 2010. View at Google Scholar
  36. S. C. Frasch, J. A. Nick, V. A. Fadok, D. L. Bratton, G. S. Worthen, and P. M. Henson, “p38 mitogen-activated protein kinase-dependent and -independent intracellular signal transduction pathways leading to apoptosis in human neutrophils,” Journal of Biological Chemistry, vol. 273, no. 14, pp. 8389–8397, 1998. View at Publisher · View at Google Scholar · View at Scopus
  37. D. T. Denhardt, “Signal-transducing protein phosphorylation cascades mediated by Ras/Rho proteins in the mammalian cell: the potential for multiplex signalling,” Biochemical Journal, vol. 318, no. 3, pp. 729–747, 1996. View at Google Scholar · View at Scopus
  38. D. F. Liao, B. Monia, N. Dean, and B. C. Berk, “Protein kinase C-ζ mediates angiotensin II activation of ERK1/2 in vascular smooth muscle cells,” Journal of Biological Chemistry, vol. 272, no. 10, pp. 6146–6150, 1997. View at Publisher · View at Google Scholar · View at Scopus
  39. P. L. Tharaux, C. Chatziantoniou, F. Fakhouri, and J. C. Dussaule, “Angiotensin II activates collagen I gene through a mechanism involving the MAP/ER kinase pathway,” Hypertension, vol. 36, no. 3, pp. 330–336, 2000. View at Google Scholar · View at Scopus
  40. T. Hannken, R. Schroeder, G. Zahner, R. A. K. Stahl, and G. Wolf, “Reactive oxygen species stimulate p44/42 mitogen-activated protein kinase and induce p27(Kip1): role in angiotensin II-mediated hypertrophy of proximal tubular cells,” Journal of the American Society of Nephrology, vol. 11, no. 8, pp. 1387–1397, 2000. View at Google Scholar · View at Scopus
  41. H. Uemura, H. Ishiguro, N. Nakaigawa et al., “Angiotensin II receptor blocker shows antiproliferative activity in prostate cancer cells: a possibility of tyrosine kinase inhibitor of growth factor,” Molecular cancer therapeutics, vol. 2, no. 11, pp. 1139–1147, 2003. View at Google Scholar · View at Scopus
  42. Y. Fujimoto, T. Sasaki, A. Tsuchida, and K. Chayama, “Angiotensin II type 1 receptor expression in human pancreatic cancer and growth inhibition by angiotensin II type 1 receptor antagonist,” FEBS Letters, vol. 495, no. 3, pp. 197–200, 2001. View at Publisher · View at Google Scholar · View at Scopus
  43. E. Rivera, O. Arrieta, P. Guevara, A. Duarte-Rojo, and J. Sotelo, “AT1 receptor is present in glioma cells; its blockage reduces the growth of rat glioma,” British Journal of Cancer, vol. 85, no. 9, pp. 1396–1399, 2001. View at Publisher · View at Google Scholar · View at Scopus
  44. Y. Beyazit, S. Aksu, I. C. Haznedaroglu et al., “Overexpression of the local bone marrow renin-angiotensin system in acute myeloid leukemia,” Journal of the National Medical Association, vol. 99, no. 1, pp. 57–63, 2007. View at Google Scholar · View at Scopus
  45. E. Vila-Porcile and P. Corvol, “Angiotensinogen, prorenin, and renin are co-localized in the secretory granules of all glandular cells of the rat anterior pituitary: an immunoultrastructural study,” Journal of Histochemistry and Cytochemistry, vol. 46, no. 3, pp. 301–311, 1998. View at Google Scholar · View at Scopus
  46. E. Vila-Porcile, A. Barret, and P. Corvol, “Secretion of renin-angiotensin system (RAS) components by normal and tumoral lactotropes: a comparative study using reverse hemolytic plaque assay (RHPA) and immunoelectron microscopy,” Journal of Histochemistry and Cytochemistry, vol. 48, no. 12, pp. 1691–1704, 2000. View at Google Scholar · View at Scopus
  47. M. Pawlikowski, “Immunohistochemical detection of angiotensin receptors AT1 and AT2 in normal rat pituitary gland, estrogen-induced rat pituitary tumor and human pituitary adenomas,” Folia Histochemica et Cytobiologica, vol. 44, no. 3, pp. 173–177, 2006. View at Google Scholar · View at Scopus
  48. W. F. Ganong, “Blood, pituitary, and brain renin-angiotensin systems and regulation of secretion of anterior pituitary gland,” Frontiers in Neuroendocrinology, vol. 14, no. 3, pp. 233–249, 1993. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Pawlikowski, S. Mucha, J. Kunert-Radek, H. Stępień, H. Pisarek, and A. Stawowy, “Is estrogen-induced pituitary hyperplasia and hyperprolactinaemia mediated by angiotensin II?” in Tissue Renin-Angiotensin Systems, A. K. Mukhopadhyay and M. K. Raizada, Eds., vol. 26, pp. 371–378, Plenum Press, New York, NY, USA, 1995. View at Google Scholar
  50. M. Otis, S. Campbell, M. D. Payet, and N. Gallo-Payet, “Angiotensin II stimulates protein synthesis and inhibits proliferation in primary cultures of rat adrenal glomerulosa cells,” Endocrinology, vol. 146, no. 2, pp. 633–642, 2005. View at Publisher · View at Google Scholar · View at Scopus
  51. M. Otis, S. Campbell, M. D. Payet, and N. Gallo-Payet, “The growth-promoting effects of angiotensin II in adrenal glomerulosa cells: an interactive tale,” Molecular and Cellular Endocrinology, vol. 273, no. 1-2, pp. 1–5, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. A. Lachowicz Ochedalska, E. Rebas, J. Kunert-Radek, M. C. Fournie-Zaluski, and M. Pawlikowski, “Angiotensins II and IV stimulate the activity of tyrosine kinases in estrogen-induced rat pituitary tumors,” Biochemical and Biophysical Research Communications, vol. 297, no. 4, pp. 931–933, 2002. View at Publisher · View at Google Scholar · View at Scopus
  53. E. Rȩbas, A. Lachowicz-Ochȩdalska, and M. Pawlikowski, “Angiotensin IV stimulates the activity of tyrosine kinases in rat anterior pituitary gland acting via AT1-like receptors?” Journal of Physiology and Pharmacology, vol. 55, no. 1, pp. 107–111, 2004. View at Google Scholar
  54. D. Ptasinska-Wnuk, J. Kunert-Radek, and M. Pawlikowski, “Angiotensins II and IV stimulate the rat anterior pituitary cell proliferation independently of the AT1 receptor subtype,” Neuroendocrinology Letters, vol. 24, no. 6, pp. 397–400, 2003. View at Google Scholar · View at Scopus
  55. S. Ahmad and P. E. Ward, “Role of aminopeptidase activity in the regulation of the pressor activity of circulating angiotensins,” Journal of Pharmacology and Experimental Therapeutics, vol. 252, no. 2, pp. 643–650, 1990. View at Google Scholar · View at Scopus
  56. L. Shang, T. Maeda, W. Xu, and S. Kishioka, “Evaluation of a novel aminopeptidase N inhibitor, in vitro, using two assay systems,” Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 23, no. 2, pp. 198–205, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. M. A. F. De Godoy, S. Dunn, and S. Rattan, “Evidence for the role of angiotensin II biosynthesis in the rat internal anal sphincter tone,” Gastroenterology, vol. 127, no. 1, pp. 127–138, 2004. View at Publisher · View at Google Scholar · View at Scopus
  58. E. Rȩbas and A. Lachowicz-Ochȩdalska, “The effect of angiotensin III on protein tyrosine kinase activity in rat pituitary,” Regulatory Peptides, vol. 130, no. 1-2, pp. 14–18, 2005. View at Publisher · View at Google Scholar · View at Scopus
  59. E. Rebas, J. Zabczyńska, and A. Lachowicz, “The effect of angiotensin 1-7 on tyrosine kinases activity in rat anterior pituitary,” Biochemical and Biophysical Research Communications, vol. 347, no. 3, pp. 581–585, 2006. View at Publisher · View at Google Scholar · View at Scopus
  60. K. Chaturvedi and D. K. Sarkar, “Mediation of basic fibroblast growth factor-induced lactotropic cell proliferation by Src-Ras-Mitogen-Activated Protein Kinase p44/42 signaling,” Endocrinology, vol. 146, no. 4, pp. 1948–1955, 2005. View at Publisher · View at Google Scholar · View at Scopus
  61. H. Yoshitomi, Y. Fujii, M. Miyazaki, N. Nakajima, N. Inagaki, and S. Seino, “Involvement of MAP kinase and c-fos signaling in the inhibition of cell growth by somatostatin,” American Journal of Physiology, vol. 272, no. 5, pp. E769–E774, 1997. View at Google Scholar · View at Scopus
  62. N. W. Cheung and S. C. Boyages, “Somatostatin-14 and its analog octreotide exert a cytostatic effect on GH3 rat pituitary tumor cell proliferation via a transient G0/G1 cell cycle block,” Endocrinology, vol. 136, no. 10, pp. 4174–4181, 1995. View at Google Scholar · View at Scopus
  63. H. Kanasaki, K. Fukunaga, K. Takahashi, K. Miyazaki, and E. Miyamoto, “Mitogen-activated protein kinase activation by stimulation with thyrotropin-releasing hormone in rat pituitary GH3 cells,” Biology of Reproduction, vol. 61, no. 1, pp. 319–325, 1999. View at Publisher · View at Google Scholar · View at Scopus
  64. R. Felix, U. Meza, and G. Cota, “Induction of classical lactotropes by epidermal growth factor in rat pituitary cell cultures,” Endocrinology, vol. 136, no. 3, pp. 939–946, 1995. View at Google Scholar · View at Scopus
  65. M. Otis and N. Gallo-Payet, “Role of MAPKs in angiotensin II-induced steroidogenesis in rat glomerulosa cells,” Molecular and Cellular Endocrinology, vol. 265-266, pp. 126–130, 2007. View at Publisher · View at Google Scholar · View at Scopus
  66. D. F. Liao, J. L. Duff, G. Daum, S. L. Pelech, and B. C. Berk, “Angiotensin II stimulates MAP kinase kinase kinase activity in vascular smooth muscle cells: Role of Raf,” Circulation Research, vol. 79, no. 5, pp. 1007–1014, 1996. View at Google Scholar · View at Scopus
  67. M. V. Chao, “Growth factor signaling: Where is the specificity?” Cell, vol. 68, no. 6, pp. 995–997, 1992. View at Publisher · View at Google Scholar · View at Scopus
  68. R. H. Chen, C. Sarnecki, and J. Blenis, “Nuclear localization and regulation of erk- and rsk-encoded protein kinases,” Molecular and Cellular Biology, vol. 12, no. 3, pp. 915–927, 1992. View at Google Scholar · View at Scopus
  69. S. Traverse, N. Gomez, H. Paterson, C. Marshall, and P. Cohen, “Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor,” Biochemical Journal, vol. 288, no. 2, pp. 351–355, 1992. View at Google Scholar · View at Scopus
  70. S. Traverse, K. Seedorf, H. Paterson, C. J. Marshall, P. Cohen, and A. Ullrich, “EGF triggers neuronal differentiation of PC12 cells that overexpress the EGF receptor,” Current Biology, vol. 4, no. 8, pp. 694–701, 1994. View at Publisher · View at Google Scholar · View at Scopus
  71. C. J. Marshall, “Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation,” Cell, vol. 80, no. 2, pp. 179–185, 1995. View at Google Scholar · View at Scopus
  72. H. Kankaanranta, P. M. De Souza, P. J. Barnes, M. Salmon, M. A. Giembycz, and M. A. Lindsay, “SB 203580, an inhibitor of p38 mitogen-activated protein kinase, enhances constitutive apoptosis of cytokine-deprived human eosinophils,” Journal of Pharmacology and Experimental Therapeutics, vol. 290, no. 2, pp. 621–628, 1999. View at Google Scholar · View at Scopus
  73. Y. Wang, S. Huang, V. P. Sah et al., “Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family,” Journal of Biological Chemistry, vol. 273, no. 4, pp. 2161–2168, 1998. View at Publisher · View at Google Scholar · View at Scopus
  74. S. Horstmann, P. J. Kahle, and G. D. Borasio, “Inhibitors of p38 mitogen-activated protein kinase promote neuronal survival in vitro,” Journal of Neuroscience Research, vol. 52, no. 4, pp. 483–490, 1998. View at Publisher · View at Google Scholar · View at Scopus
  75. H. Kanasaki, K. Fukunaga, K. Takahashi, K. Miyazaki, and E. Miyamoto, “Involvement of p38 mitogen-activated protein kinase activation in bromocriptine-induced apoptosis in rat pituitary GH3 cells,” Biology of Reproduction, vol. 62, no. 6, pp. 1486–1494, 2000. View at Google Scholar · View at Scopus
  76. M. Pouliot, J. Baillargeon, J. C. Lee, L. G. Cleland, and M. J. James, “Inhibition of prostaglandin endoperoxide synthase-2 expression in stimulated human monocytes by inhibitors of p38 mitogen-activated protein kinase,” Journal of Immunology, vol. 158, no. 10, pp. 4930–4937, 1997. View at Google Scholar · View at Scopus
  77. T. Force and J. V. Bonventre, “Growth factors and mitogen-activated protein kinases,” Hypertension, vol. 31, no. 1, pp. 152–161, 1998. View at Google Scholar · View at Scopus